Type 2 Diabetes Research
As the worldwide incidence of diabetes soars well beyond the quarter-billion mark, Joslin scientists lead in bench-to-bedside research that progresses toward new medications and best treatments.
As salsalate does well in clinical trials for type 2 diabetes, Joslin scientists delve deeper into how the drug works.
Genetic analyses help to unravel the complexities of coronary artery disease.
What Dr. Laurie Goodyear is learning on the molecular level about exercise has practical implications for how we treat people with type 2 diabetes.
Joslin researchers unveil secrets of the fat that may make you thinner—and less prone to diabetes.
Joslin scientists analyze what can go wrong in diabetic pregnancies, and the nongenetic ways in which risk of diabetes can be handed down.
Joslin researchers pinpoint molecular pathway activated years before people develop type 2 diabetes.
In a step toward novel weight-loss therapies, Joslin scientists identify cells in mice that can be triggered to transform into energy-burning brown fat.
Page last updated: March 12, 2014